Zabransky DJ, Yarchoan M, Ho WJ. Reply: The Hepa 1-6 may not be suitable for use in hepatocellular carcinoma models to explore responses to drug therapy. Hepatology 2023 Dec 26. doi: 10.1097/HEP.0000000000000738.
PMID: 38147327